Asherman's syndrome epidemiology and demographics: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| (2 intermediate revisions by the same user not shown) | |||
| Line 3: | Line 3: | ||
'''Editor(s)-in-Chief:''' {{CMG}} [[User:Csinfor|Canan S Fornusek, Ph.D.]]; '''Associate Editor-In-Chief:''' {{skhan}} | '''Editor(s)-in-Chief:''' {{CMG}} [[User:Csinfor|Canan S Fornusek, Ph.D.]]; '''Associate Editor-In-Chief:''' {{skhan}} | ||
==Overview== | ==Overview== | ||
<br /> | Asherman's Syndrome may occur in up to 13% of women undergoing a termination of pregnancy during the first trimester, and 30% in women undergoing a [[Dilation and curettage (patient information)|dilation and curettage]] (D&C) after a late '''spontaneous''' abortion. Structural placental abnormalities and previous procedures done in the uterus increase the risk.<br /> | ||
==Epidemiology and Demographics== | ==Epidemiology and Demographics== | ||
The true prevalence of Asherman’s syndrome is unclear. The condition is estimated to affect 1.5% of women undergoing HSG <ref name="Dmowski">{{cite journal |author=Dmowski WP, Greenblatt RB. |title=Asherman’s syndrome and risk of placenta accreta |journal=Obstet Gynecol |volume=34 |issue=2 |pages=288–299. |year=1969 |pmid=5816312 |doi=}} | The true prevalence of Asherman’s syndrome is unclear. The condition is estimated to affect 1.5% of women undergoing [[Hysterosalpingography|HSG]] <ref name="Dmowski">{{cite journal |author=Dmowski WP, Greenblatt RB. |title=Asherman’s syndrome and risk of placenta accreta |journal=Obstet Gynecol |volume=34 |issue=2 |pages=288–299. |year=1969 |pmid=5816312 |doi=}} | ||
</ref>, between 5 and 39% of women with recurrent miscarriage <ref name="Rabau">{{cite journal |author=Rabau E, David A. |title=Intrauterine adhesions:etiology, prevention, and treatment |journal=Obstet Gynecol |volume=22 |pages=626–629. |year=1963 |pmid=14082285 |doi=}}</ref><ref name="Toaf">{{cite journal |author=Toaff R. |title=Some remarks on posttraumatic uterine adhesions.in French |journal=Rev Fr Gynecol Obstet |volume=61 |issue=7 |pages=550–552. |year=1966 |pmid=5940506 |doi=}} | </ref>, between 5 and 39% of women with recurrent [[miscarriage]] <ref name="Rabau">{{cite journal |author=Rabau E, David A. |title=Intrauterine adhesions:etiology, prevention, and treatment |journal=Obstet Gynecol |volume=22 |pages=626–629. |year=1963 |pmid=14082285 |doi=}}</ref><ref name="Toaf">{{cite journal |author=Toaff R. |title=Some remarks on posttraumatic uterine adhesions.in French |journal=Rev Fr Gynecol Obstet |volume=61 |issue=7 |pages=550–552. |year=1966 |pmid=5940506 |doi=}} | ||
</ref><ref name="Ventolini">{{cite journal |author=Ventolini G, Zhang M, Gruber J. |title=Hysteroscopy in the evaluation of patients with recurrent pregnancy loss: a cohort study in a primary care population |journal=Surg Endosc |volume=18 |issue=12 |pages=1782–1784. |year=2004 |pmid=15809790 |doi=10.1007/s00464-003-8258-y}}</ref> and up to 40% of patients who have undergone D&C for retained products of conception <ref name="Westendorp">{{cite journal |author=Westendorp ICD, Ankum WM, Mol BWJ, Vonk J. |title=Prevalence of Asherman’s syndrome after secondary removal of placental remnants or a repeat curettage for incomplete abortion |journal=Hum Reprod |volume=13 |issue=12 |pages=3347–3350. |year=1998 |pmid=9886512 |doi=10.1093/humrep/13.12.3347}} | </ref><ref name="Ventolini">{{cite journal |author=Ventolini G, Zhang M, Gruber J. |title=Hysteroscopy in the evaluation of patients with recurrent pregnancy loss: a cohort study in a primary care population |journal=Surg Endosc |volume=18 |issue=12 |pages=1782–1784. |year=2004 |pmid=15809790 |doi=10.1007/s00464-003-8258-y}}</ref> and up to 40% of patients who have undergone D&C for retained products of conception <ref name="Westendorp">{{cite journal |author=Westendorp ICD, Ankum WM, Mol BWJ, Vonk J. |title=Prevalence of Asherman’s syndrome after secondary removal of placental remnants or a repeat curettage for incomplete abortion |journal=Hum Reprod |volume=13 |issue=12 |pages=3347–3350. |year=1998 |pmid=9886512 |doi=10.1093/humrep/13.12.3347}} | ||
</ref>. It may occur in up to 13% of women undergoing a termination of pregnancy during the first trimester, and 30% in women undergoing a dilation and curettage (D and C) after a late '''spontaneous''' abortion. | </ref>. It may occur in up to 13% of women undergoing a [[termination of pregnancy]] during the first [[Pregnancy|trimester]], and 30% in women undergoing a dilation and curettage (D and C) after a late [[Spontaneous abortion|'''spontaneous''' abortion]]. | ||
Women with placental abnormalities (e.g., placenta increta) may have a higher risk of developing Asherman syndrome as the placenta adheres to deeper layers within the uterus and becomes more difficult to remove. The incidence may be as high as 23.4% in patients undergoing procedures two to four weeks after the initial procedure for a vaginal delivery or missed abortion. The risk increases for patients undergoing repeated procedures for bleeding or repeated elective termination of pregnancies. | Women with placental abnormalities (e.g., [[Placenta accreta|placenta increta]]) may have a higher risk of developing Asherman syndrome as the placenta adheres to deeper layers within the [[uterus]] and becomes more difficult to remove. The incidence may be as high as 23.4% in patients undergoing procedures two to four weeks after the initial procedure for a vaginal delivery or missed abortion. The risk increases for patients undergoing repeated procedures for bleeding or repeated elective termination of pregnancies. | ||
It is found in 1.5% of women evaluated with a hysterosalpingogram (HSG) for infertility, between 5 and 39% of women with recurrent miscarriage. Asherman’s Syndrome may occur in 31% of women after the initial hysteroscopic resection of leiomyoma, and up to 46% after the second hysteroscopic resection. | It is found in 1.5% of women evaluated with a [[Hysterosalpingography|hysterosalpingogram]] (HSG) for infertility, between 5 and 39% of women with recurrent miscarriage. Asherman’s Syndrome may occur in 31% of women after the initial hysteroscopic resection of [[leiomyoma]], and up to 46% after the second hysteroscopic resection.<ref name="pmid30454053">{{cite journal| author=Chikazawa K, Imai K, Liangcheng W, Sasaki S, Horiuchi I, Kuwata T | display-authors=etal| title=Detection of Asherman's syndrome after conservative management of placenta accreta: a case report. | journal=J Med Case Rep | year= 2018 | volume= 12 | issue= 1 | pages= 344 | pmid=30454053 | doi=10.1186/s13256-018-1869-7 | pmc=6245912 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=30454053 }} </ref><ref name="pmid30335256">Tchente NC, Brichant G, Nisolle M (2018) [https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&retmode=ref&cmd=prlinks&id=30335256 [Asherman's syndrome<span> </span>: management after curettage following a postnatal placental retention and literature review].] ''Rev Med Liege'' 73 (10):508-512. PMID: [https://pubmed.gov/30335256 30335256]</ref> | ||
==References== | ==References== | ||
Latest revision as of 17:35, 4 September 2022
|
Asherman's syndrome Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Asherman's syndrome epidemiology and demographics On the Web |
|
American Roentgen Ray Society Images of Asherman's syndrome epidemiology and demographics |
|
Asherman's syndrome epidemiology and demographics in the news |
|
Risk calculators and risk factors for Asherman's syndrome epidemiology and demographics |
Editor(s)-in-Chief: Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Canan S Fornusek, Ph.D.; Associate Editor-In-Chief: Saud Khan M.D.
Overview
Asherman's Syndrome may occur in up to 13% of women undergoing a termination of pregnancy during the first trimester, and 30% in women undergoing a dilation and curettage (D&C) after a late spontaneous abortion. Structural placental abnormalities and previous procedures done in the uterus increase the risk.
Epidemiology and Demographics
The true prevalence of Asherman’s syndrome is unclear. The condition is estimated to affect 1.5% of women undergoing HSG [1], between 5 and 39% of women with recurrent miscarriage [2][3][4] and up to 40% of patients who have undergone D&C for retained products of conception [5]. It may occur in up to 13% of women undergoing a termination of pregnancy during the first trimester, and 30% in women undergoing a dilation and curettage (D and C) after a late spontaneous abortion.
Women with placental abnormalities (e.g., placenta increta) may have a higher risk of developing Asherman syndrome as the placenta adheres to deeper layers within the uterus and becomes more difficult to remove. The incidence may be as high as 23.4% in patients undergoing procedures two to four weeks after the initial procedure for a vaginal delivery or missed abortion. The risk increases for patients undergoing repeated procedures for bleeding or repeated elective termination of pregnancies.
It is found in 1.5% of women evaluated with a hysterosalpingogram (HSG) for infertility, between 5 and 39% of women with recurrent miscarriage. Asherman’s Syndrome may occur in 31% of women after the initial hysteroscopic resection of leiomyoma, and up to 46% after the second hysteroscopic resection.[6][7]
References
- ↑ Dmowski WP, Greenblatt RB. (1969). "Asherman's syndrome and risk of placenta accreta". Obstet Gynecol. 34 (2): 288–299. PMID 5816312.
- ↑ Rabau E, David A. (1963). "Intrauterine adhesions:etiology, prevention, and treatment". Obstet Gynecol. 22: 626–629. PMID 14082285.
- ↑ Toaff R. (1966). "Some remarks on posttraumatic uterine adhesions.in French". Rev Fr Gynecol Obstet. 61 (7): 550–552. PMID 5940506.
- ↑ Ventolini G, Zhang M, Gruber J. (2004). "Hysteroscopy in the evaluation of patients with recurrent pregnancy loss: a cohort study in a primary care population". Surg Endosc. 18 (12): 1782–1784. doi:10.1007/s00464-003-8258-y. PMID 15809790.
- ↑ Westendorp ICD, Ankum WM, Mol BWJ, Vonk J. (1998). "Prevalence of Asherman's syndrome after secondary removal of placental remnants or a repeat curettage for incomplete abortion". Hum Reprod. 13 (12): 3347–3350. doi:10.1093/humrep/13.12.3347. PMID 9886512.
- ↑ Chikazawa K, Imai K, Liangcheng W, Sasaki S, Horiuchi I, Kuwata T; et al. (2018). "Detection of Asherman's syndrome after conservative management of placenta accreta: a case report". J Med Case Rep. 12 (1): 344. doi:10.1186/s13256-018-1869-7. PMC 6245912. PMID 30454053.
- ↑ Tchente NC, Brichant G, Nisolle M (2018) [Asherman's syndrome : management after curettage following a postnatal placental retention and literature review.] Rev Med Liege 73 (10):508-512. PMID: 30335256